Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
CleanSpace HoldingsASX:CSX 27 EV-to-FCF is 15.28 as of Jul. 25, 2026. GuruFocus rates ASX:CSX with a GF Score™ of 27/100 and a GF Value™ of A$0.55 (Modestly Undervalued). The stock has 1 warning sign investors should review. Among 414 Medical Devices & Instruments companies, CleanSpace Holdings ranks better than 71.74% on this metric.
EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, CleanSpace Holdings's Enterprise Value is A$24.21 Mil.
CleanSpace Holdings's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2025 was A$1.58 Mil. Therefore, CleanSpace Holdings's EV-to-FCF for today is 15.28.
The historical rank and industry rank for CleanSpace Holdings's EV-to-FCF or its related term are showing as below:
ASX:CSX'
s EV-to-FCF Range Over the Past 10 Years
Min: -21.24 Med: -1.01 Max: 60.15
Current: 14.24
During the past 6 years, the highest EV-to-FCF of CleanSpace Holdings was 60.15. The lowest was -21.24. And the median was -1.01.
ASX:CSX's EV-to-FCF is ranked better than 71.74% of 414
companies
in the Medical Devices & Instruments industry
Industry Median: 22.995
vs ASX:CSX: 14.24
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
CleanSpace Holdings's PE Ratio (TTM) for today is calculated as:
CleanSpace Holdings's share price for today is A$0.395.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. CleanSpace Holdings's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 was A$0.023.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
CleanSpace Holdings EV-to-FCF Related Terms
CleanSpace Holdings EV-to-FCF Historical Data
* Premium members only.
The historical data trend for CleanSpace Holdings's EV-to-FCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, CleanSpace Holdings's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
CleanSpace Holdings EV-to-FCF vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, CleanSpace Holdings's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where CleanSpace Holdings's EV-to-FCF falls into.
CleanSpace Holdings's current Enterprise Value is A$24.21 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. CleanSpace Holdings's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2025 was A$1.58 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
CleanSpace Holdings (ASX:CSX) has a EV-to-FCF of 15.28 as of Jul. 25, 2026. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on CleanSpace Holdings and its competitors. According to the industry distribution chart, CleanSpace Holdings ranks #117 out of 414 companies in the Medical Devices & Instruments industry, placing it in the top 28.3%.
Is CleanSpace Holdings' EV-to-FCF too high?
CleanSpace Holdings' current EV-to-FCF is 15.28. The Medical Devices & Instruments industry median EV-to-FCF is 23.00. CleanSpace Holdings' value of 15.28 is 33.6% below this industry median. Based on the distribution chart, CleanSpace Holdings ranks #117 out of 414 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, CleanSpace Holdings has a GF Score™ of 27/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does CleanSpace Holdings' EV-to-FCF compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, CleanSpace Holdings ranks #117 out of 414 companies for EV-to-FCF. This puts CleanSpace Holdings in the upper half of its industry. The industry median EV-to-FCF is 23.00. CleanSpace Holdings' value of 15.28 is 33.6% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-FCF for a Medical Devices & Instruments company?
The median EV-to-FCF among Medical Devices & Instruments companies is 23.00, based on 414 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-FCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-FCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. CleanSpace Holdings's current EV-to-FCF of 15.28 is 33.6% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-FCF mean?
A high EV-to-FCF can signal that a stock is expensive relative to its fundamentals. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on CleanSpace Holdings and its competitors. For the Medical Devices & Instruments industry, the median EV-to-FCF is 23.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. CleanSpace Holdings's current EV-to-FCF is 15.28. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is CleanSpace Holdings stock overvalued right now?
Based on GuruFocus' analysis, CleanSpace Holdings (ASX:CSX) is currently considered Modestly Undervalued. The stock's GF Value™ is A$0.55, compared to a current price of A$0.40 — trading 28.2% below its estimated fair value. The current EV-to-FCF is 15.28 and 33.6% below the Medical Devices & Instruments industry median of 23.00. CleanSpace Holdings' overall GF Score™ is 27/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-FCF calculated?
EV-to-FCF is calculated from a company's financial statements. For CleanSpace Holdings (ASX:CSX), the current EV-to-FCF is 15.28 as of Jul. 25, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is CleanSpace Holdings (ASX:CSX) Overvalued in 2026?
Based on GuruFocus' analysis, CleanSpace Holdings stock appears to be undervalued.
The current stock price of A$0.40 is trading 28.2% below its estimated GF Value™ of A$0.55.
GuruFocus considers CleanSpace Holdings to be Modestly Undervalued.
Key valuation signals for ASX:CSX:
EV-to-FCF: 15.28
GF Value™: A$0.55 vs. price of A$0.40 (28.2% below fair value)
Industry Position: 33.6% below the Medical Devices & Instruments median (#117 of 414)
No single metric tells the full story. See the ASX:CSX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
CleanSpace Holdings Ltd manufactures and sells respirators and related products and services. Its products include Compare, CleanSpace HALO, CleanSpace ULTRA, Masks, Filters, and Compatible Products. The company's operating segment is based on regions that include, Europe, Asia, and North America, and the majority of its revenue is generated from Europe.
27GF Score
Get the complete analysis for ASX:CSX
EV-to-FCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ASX:CSX has been successfully added to your 
